Synalloy Corporation — Form 10-Q Summary
Filing identity: The request metadata names Ascent Industries Co., but the filing is for Synalloy Corporation (NASDAQ: SYNL). The report covers the quarter and six months ended June 30, 2020; it was filed September 3, 2020.
Business context and reporting period
Synalloy operates Metals and Specialty Chemicals segments. Metals includes welded pipe and tube, liquid storage tanks and separation equipment, and seamless carbon pipe and tube distribution. Specialty Chemicals manufactures and tolls specialty chemical products.
Financial performance and liquidity
- Revenue: Second-quarter sales were $66.1 million, down 16.0% year over year; first-half sales were $140.8 million, down 13.9%.
- Profitability: Q2 gross profit was $4.4 million (6.6% margin), versus $7.8 million (10.0%) a year earlier. First-half gross profit was $11.5 million (8.2%), versus $16.5 million (10.1%). Q2 net loss was $7.0 million, or $0.77 per diluted share; first-half net loss was $8.1 million, or $0.90 per diluted share.
- Operating results by segment: Q2 Metals sales fell 19.4% to $52.0 million and the segment recorded a $9.2 million operating loss. Specialty Chemicals sales were $14.1 million, down 1.1%, while operating income rose to $2.0 million from $0.9 million.
- Cash flow: First-half operating cash flow was negative $0.2 million, compared with positive $13.2 million in 2019. Investing provided $0.8 million; financing provided $0.2 million. Cash increased by $0.8 million to $1.4 million.
- Debt and liquidity: Total borrowings were $78.6 million at June 30, including $64.3 million on the revolving line and $14.3 million on the term loan. Available revolver capacity was $7.2 million. Current assets were $147.7 million and current liabilities $40.1 million; the reported current ratio was 3.7. Operating lease liabilities totaled $37.5 million.
- Other metrics: Total assets were $251.4 million and shareholders’ equity was $98.1 million. The company reported $4.6 million of first-half adjusted EBITDA, versus $8.2 million in 2019; this is a non-GAAP measure.
Material changes versus prior comparable period
- Metals drove the sales decline, with a particularly sharp contraction in Palmer’s tanks and separation-equipment business. COVID-19-related operating curtailments and weakness in oil and gas markets contributed.
- Net results included $6.1 million of non-cash asset impairments related to Palmer, $2.7 million of Q2 proxy-contest costs, and a $1.1 million Q2 unrealized gain on equity investments. First-half inventory price-change losses were $3.9 million, compared with $5.2 million in 2019.
- Specialty Chemicals operating income improved, supported by cost reductions, lower manufacturing costs, and demand for hand sanitizer and cleaning aids.
- First-half operating cash flow weakened substantially, reflecting working-capital movements, including receivables, inventory, and accrued income taxes.
Outlook, risks, contingencies, and unusual items
- Management provided no numerical earnings or revenue guidance. It said the duration and ultimate financial effects of COVID-19 remained uncertain and that it could not predict the full impact.
- The company reported a technical fixed-charge-coverage covenant default for June 30. Amendments signed July 31 and August 13 changed the covenant calculation to include proxy-contest costs and up to $6.0 million of Palmer impairment charges, effective for Q2 and the next three quarters. Management reported a 1.39 fixed-charge-coverage ratio and $67.4 million tangible net worth at quarter-end.
- Management plans to pursue a sale and exit of Palmer. A $1.3 million Palmer customer-list intangible was written down to zero; other Palmer inventory and long-lived asset write-downs contributed to the $6.1 million impairment charge.
- Welded Pipe & Tube goodwill of $16.2 million passed its impairment test, but estimated fair value exceeded carrying value by only 1.7%. Management said goodwill was at risk and estimated a 39-basis-point discount-rate increase could result in an approximately $0.7 million impairment.
- Disclosure controls were deemed ineffective because of a material weakness in the control environment. The company was developing remediation measures. A Board-commissioned investigation of a hotline complaint found no evidence of intentional misconduct, bad faith, or criminal acts.
- The period included a proxy contest; three new directors were elected, and the company appointed a new CFO effective June 30 and a new Board chair in July. The shareholder-rights plan adopted in March expired June 28.
- Management said ordinary-course legal matters were not expected to have a material adverse effect. COVID-19, customer and market demand, raw-material pricing, covenant compliance, impairment assumptions, and leadership transitions remain significant risks.
Important facts for investors to verify
- Confirm the filing issuer is Synalloy Corporation, not the company named in the request metadata.
- Review the amended credit-covenant terms, remaining borrowing capacity, and subsequent covenant compliance.
- Track Palmer’s proposed sale or exit, operating status, and any further impairments.
- Assess whether Metals demand, pricing, and gross margins recover, and whether Specialty Chemicals’ stronger results persist.
- Monitor remediation of the material weakness and the effects of Board and executive transitions.
- Distinguish GAAP losses and cash flows from management’s non-GAAP adjusted EBITDA and adjusted earnings measures.